TZAP expression was lower in AD patients with higher T stage (p = 0.005), higher N stage (p = 0.065), and epidermal growth factor receptor (EGFR) mutation positivity (p = 0.066), although the N stage and EGFR mutation were not statistically significant. Here, EGFR is linked to Alzheimer disease.